Brekke, Kurt R.; Grasdal, Astrid L.; Holms, Tor Helge - In: European Economic Review 53 (2009) 2, pp. 170-185
We study the relationship between regulatory regimes and pharmaceutical firms' pricing strategies using a unique policy experiment in Norway, which in 2003 introduced a reference price (RP) system called "index pricing" for a sub-sample of off-patent pharmaceuticals, replacing the existing price...